![Hui Jun Wang](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Hui Jun Wang
Chief Executive Officer at
OBI PHARMA, INC.
Profile
Hui Jun Wang is currently Chief Executive Officer at OBI Pharma, Inc. and Chairman at Obigen Pharma, Inc. since 2023.
Formerly, served as Vice President & Global Head-Regulatory Science at Bristol-Myers Squibb (Taiwan) Ltd. Earned a doctorate from the University of Notre Dame.
Hui Jun Wang active positions
| Companies | Position | Start |
|---|---|---|
| OBIGEN PHARMA INC. | Chairman | 2023-12-28 |
| OBI PHARMA, INC. | Chief Executive Officer | - |
Former positions of Hui Jun Wang
| Companies | Position | End |
|---|---|---|
Bristol-Myers Squibb (Taiwan) Ltd. | Corporate Officer/Principal | - |
Training of Hui Jun Wang
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
5
1st degree connections
4
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
University of Notre Dame
 University of Notre Dame Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bristol-Myers Squibb (Taiwan) Ltd. | |
OBI Pharma, Inc.
 OBI Pharma, Inc. Pharmaceuticals: MajorHealth Technology Manufactures anti-infective and immunotherapy drugs | Health Technology |
Obigen Pharma, Inc.
 Obigen Pharma, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops and manufactures botulinum toxin products | Health Technology |
- Stock Market
- Insiders
- Hui Jun Wang
